Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.

PubWeight™: 2.77‹?› | Rank: Top 1%

🔗 View Article (PMID 15551205)

Published in J Infect Dis on November 22, 2004

Authors

Nubia Muñoz1, Fabián Méndez, Héctor Posso, Mónica Molano, Adrian J C van den Brule, Margarita Ronderos, Chris Meijer, Alvaro Muñoz, Instituto Nacional de Cancerologia HPV Study Group

Author Affiliations

1: Instituto Nacional de Cancerologia, Bogota, Colombia.

Associated clinical trials:

Zinc Sulfate for Human Papillomavirus (HPV) | NCT03404310

Articles citing this

Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet (2011) 4.70

Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst (2010) 3.95

The known unknowns of HPV natural history. J Clin Invest (2011) 2.39

Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep (2009) 2.31

Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis (2010) 2.03

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73

Human papillomavirus and HPV vaccines: a review. Bull World Health Organ (2007) 1.55

Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res (2010) 1.50

EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer (2014) 1.44

Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev (2008) 1.44

Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog (2008) 1.44

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39

Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. Br J Cancer (2009) 1.37

Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev (2010) 1.36

Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women. Cancer Res (2012) 1.31

Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev (2010) 1.25

Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer (2012) 1.23

Evidence and impact of human papillomavirus latency. Open Virol J (2012) 1.20

Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev (2009) 1.18

Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology. Obstet Gynecol (2008) 1.13

Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination. Cancer Causes Control (2009) 1.07

Human papillomavirus infection in Beijing, People's Republic of China: a population-based study. Br J Cancer (2009) 1.06

Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling. Int J Cancer (2010) 1.04

Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer (2009) 1.01

An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol (2014) 0.99

Ensuring access to HPV vaccines through integrated services: a reproductive health perspective. Bull World Health Organ (2007) 0.98

Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women. Sex Transm Dis (2012) 0.96

Cervical human papillomavirus screening among older women. Emerg Infect Dis (2005) 0.96

Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women. Sex Transm Dis (2009) 0.96

Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection. J Infect Dis (2014) 0.94

New insights into cervical cancer screening. J Gynecol Oncol (2012) 0.92

High-risk human papillomavirus infection in HIV-positive African women living in Europe. J Int AIDS Soc (2013) 0.91

Higher prevalence of human papillomavirus infection in migrant women from Latin America in Spain. Sex Transm Infect (2006) 0.90

Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus. J Virol Methods (2009) 0.90

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis (2013) 0.90

Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study. J Clin Microbiol (2010) 0.89

Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis (2012) 0.89

The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types. Cancer Epidemiol Biomarkers Prev (2010) 0.89

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females. ISRN Obstet Gynecol (2011) 0.89

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J (2013) 0.88

Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58. Clin Vaccine Immunol (2014) 0.88

Treatability by cryotherapy in a screen-and-treat strategy. J Low Genit Tract Dis (2009) 0.88

Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2013) 0.87

Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med (2015) 0.87

Sensitive HPV genotyping based on the flow-through hybridization and gene chip. J Biomed Biotechnol (2012) 0.87

An update on oral human papillomavirus infection. Indian J Sex Transm Dis (2013) 0.85

Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. Int J Cancer (2014) 0.84

Incident Detection of High-Risk Human Papillomavirus Infections in a Cohort of High-Risk Women Aged 25-65 Years. J Infect Dis (2016) 0.84

Short-term natural history of high-risk human papillomavirus infection in mid-adult women sampled monthly. Int J Cancer (2015) 0.83

Management of adolescents who have abnormal cytology and histology. Obstet Gynecol Clin North Am (2008) 0.83

Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis. J Infect Dis (2014) 0.82

Incident cervical infections with high- and low-risk human papillomavirus (HPV) infections among mothers in the prospective Finnish Family HPV Study. BMC Infect Dis (2011) 0.81

Results from a dose-response study using 3,3'-diindolylmethane in the K14-HPV16 transgenic mouse model: cervical histology. Cancer Prev Res (Phila) (2011) 0.81

To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings. Int J Cancer (2016) 0.81

Obesity and human papillomavirus infection in perimenopausal women. J Infect Dis (2013) 0.80

Cervical Cytology and Human Papillomavirus Testing in Adolescent Women: Implications in Management of a Positive HPV Test. Patholog Res Int (2014) 0.80

Human papillomavirus disease and vaccines in adolescents. Adolesc Med State Art Rev (2010) 0.80

The association of current hormonal contraceptive use with type-specific HPV detection. Sex Transm Infect (2011) 0.79

Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am (2012) 0.78

Conservative management of adolescents with abnormal cytology and histology. J Natl Compr Canc Netw (2008) 0.77

The Incidence of Human Papillomavirus in Tanzanian Adolescent Girls Before Reported Sexual Debut. J Adolesc Health (2015) 0.77

Persistence or clearance of human papillomavirus infections in women in Ouro Preto, Brazil. Biomed Res Int (2013) 0.77

Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open (2017) 0.77

Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia. PLoS One (2013) 0.76

Position paper--HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians. Eur J Pediatr (2010) 0.76

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study. Int J Cancer (2016) 0.76

A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. BMC Infect Dis (2013) 0.75

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst (2016) 0.75

Human Papillomavirus Infection, Infertility, and Assisted Reproductive Outcomes. J Pathog (2015) 0.75

Cross-sectional study about primary health care professionals views on the inclusion of the vaccine against human papillomavirus in the vaccine schedules. Infect Agent Cancer (2015) 0.75

Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico. BMC Infect Dis (2016) 0.75

An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study. Papillomavirus Res (2015) 0.75

Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic. Sex Transm Infect (2012) 0.75

Risk factors and distribution of oncogenic strains of human papilloma virus in women presenting for cervical cancer screening in Port Harcourt, Nigeria. Pan Afr Med J (2016) 0.75

Persistent infection with high-risk human papilloma viruses: cohort study, Mérida, Venezuela. Ecancermedicalscience (2015) 0.75

Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings. Ann Lab Med (2017) 0.75

Articles by these authors

New equations to estimate GFR in children with CKD. J Am Soc Nephrol (2009) 11.48

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81

HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60

Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain (2005) 4.27

Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med (2007) 3.96

Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol (2006) 3.84

Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol (2005) 3.58

Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth. Obstet Gynecol (2011) 3.25

Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol (2013) 2.64

Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA (2007) 2.59

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS (2005) 2.48

Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS (2005) 2.42

Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS (2008) 2.19

Pelvic muscle strength after childbirth. Obstet Gynecol (2012) 2.13

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res (2006) 2.08

The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis (2005) 2.07

Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies. Stat Med (2004) 2.04

Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int (2012) 1.93

Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis (2005) 1.86

Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med (2009) 1.82

Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med (2002) 1.75

The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med (2007) 1.70

Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS (2014) 1.66

Extracellular volume and glomerular filtration rate in children with chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.57

Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol (2002) 1.48

ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch (2006) 1.47

Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines. Int J Epidemiol (2007) 1.45

Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A (2004) 1.45

Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease. Kidney Int (2010) 1.39

Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila) (2011) 1.37

Pelvic floor disorders after vaginal birth: effect of episiotomy, perineal laceration, and operative birth. Obstet Gynecol (2012) 1.31

Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit. Am J Trop Med Hyg (2005) 1.23

Cervical cancer control, priorities and new directions. Int J Cancer (2004) 1.23

Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety. AIDS (2004) 1.22

Validation of creatinine assays utilizing HPLC and IDMS traceable standards in sera of children. Pediatr Nephrol (2008) 1.20

Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15

Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res (Phila) (2013) 1.14

Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology (2004) 1.13

Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain (2013) 1.13

Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women. J Med Virol (2002) 1.13

Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am J Trop Med Hyg (2007) 1.13

Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis (2011) 1.12

The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol (2010) 1.12

Feline leukemia virus and other pathogens as important threats to the survival of the critically endangered Iberian lynx (Lynx pardinus). PLoS One (2009) 1.12

Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine (2008) 1.11

Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int (2011) 1.09

Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend (2006) 1.08

Antibody response to Plasmodium vivax antigens in Fy-negative individuals from the Colombian Pacific coast. Am J Trop Med Hyg (2005) 1.07

Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology (2010) 1.06

The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. Am J Epidemiol (2013) 1.06

Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf (2009) 1.04

Strategies for chemoprevention of liver cancer. Eur J Cancer Prev (2002) 1.04

[Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia]. Rev Panam Salud Publica (2005) 1.03

Use of area under the curve to characterize transmission potential after antimalarial treatment. Am J Trop Med Hyg (2006) 1.03

Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias. Am J Epidemiol (2011) 1.02

Leishmania (Viannia) infection in the domestic dog in Chaparral, Colombia. Am J Trop Med Hyg (2011) 1.02

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01

Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res (2003) 0.99

Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users. AIDS (2004) 0.99

Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs. Clin Infect Dis (2007) 0.99

Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer (2005) 0.98

Survival benefit of liver transplantation and the effect of underlying liver disease. Surgery (2009) 0.97

Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients. Carcinogenesis (2003) 0.96

The role of smoking and alcohol intake in the development of high-grade squamous intraepithelial lesions among high-risk HPV-positive women. Acta Obstet Gynecol Scand (2006) 0.94

Longitudinal changes in overactive bladder and stress incontinence among parous women. Neurourol Urodyn (2014) 0.93

An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend (2003) 0.92

Rosuvastatin: an independent analysis of risks and benefits. MedGenMed (2006) 0.91

E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature. Virology (2010) 0.90

Methods for characterizing differences in longitudinal glomerular filtration rate changes between children with glomerular chronic kidney disease and those with nonglomerular chronic kidney disease. Am J Epidemiol (2011) 0.89

Longitudinal formulas to estimate GFR in children with CKD. Clin J Am Soc Nephrol (2009) 0.89

Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One (2012) 0.88

Assessing the effect of interventions in the context of mixture distributions with detection limits. Stat Med (2005) 0.86

Bimodal virological response to antiretroviral therapy for HIV infection: an application using a mixture model with left censoring. J Epidemiol Community Health (2006) 0.86

Vaginal parity and pelvic organ prolapse. J Reprod Med (2010) 0.84

Survival attributable to an exposure. Stat Med (2009) 0.84

Multilevel competing risks in the evaluation of nosocomial infections: time to move on from proportional hazards and even from hazards altogether. Crit Care (2014) 0.82

[Helicobacter pylori genotypes in non atrophic gastritis are different of the found in peptic ulcer, premalignant lesions and gastric cancer in Colombia]. Rev Med Chil (2002) 0.82

Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy. AIDS (2003) 0.81

Improved estimation of the distribution of suppressed plasma HIV-1 RNA in men receiving effective antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 0.81

Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites. Am J Trop Med Hyg (2011) 0.80

Acceleration to death from liver cancer in people with hepatitis B viral mutations detected in plasma by mass spectrometry. Cancer Epidemiol Biomarkers Prev (2007) 0.80

Virologic and immunologic values allowing safe deferral of antiretroviral therapy. AIDS (2002) 0.80

Epinephrine-induced hyperpolarization of islet cells without KATP channels. Am J Physiol Endocrinol Metab (2003) 0.80

Joint hypermobility, obstetrical outcomes, and pelvic floor disorders. Int Urogynecol J (2012) 0.79

HPV prevalence in Colombian women with cervical cancer: implications for vaccination in a developing country. Infect Dis Obstet Gynecol (2009) 0.79

Hepatitis B virus serum profiles in injection drug users and rates of immunization over time in Barcelona: 1987-2006. Drug Alcohol Depend (2010) 0.79

Body iron stores as predictors of insulin resistance in apparently healthy urban Colombian men. Biol Trace Elem Res (2011) 0.78

Membranous glomerulonephritis in the Iberian lynx (Lynx pardinus). Vet Immunol Immunopathol (2007) 0.78

Re: Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst (2004) 0.78

No high-risk human papillomavirus infection in prostate cancer tissues. Scand J Infect Dis (2011) 0.77

[Evaluation of early manifestations of chronic no transmitted diseases risk in school population in Cali - Colombia]. Arch Latinoam Nutr (2005) 0.77

[Major birth defects in a third-level hospital in Cali, Colombia, 2004-2008]. Rev Salud Publica (Bogota) (2011) 0.77

Dietary amelioration of Helicobacter pylori infection: design criteria for a clinical trial. Cancer Epidemiol Biomarkers Prev (2004) 0.76

Determination of serum biochemical reference intervals for the Iberian lynx (Lynx pardinus). Vet J (2008) 0.76

[Impact of a waste disposal site on adult respiratory health]. Biomedica (2012) 0.76

In reply: pelvic muscle. Obstet Gynecol (2013) 0.75

[Impact of an open waste disposal site on the occurrence of respiratory symptoms and on health care costs of children]. Biomedica (2009) 0.75

Blood lead levels in schoolchildren living near an industrial zone in Cali, Colombia: the role of socioeconomic condition. Biol Trace Elem Res (2012) 0.75